MetroDerm Funding: How Much Did They Raise & Key Investors

How Much Did MetroDerm Raise?
Funding & Key Investors

MetroDerm, P.C. has successfully secured a major strategic investment, bringing its total capital accumulation to $2.3M. This latest infusion of $1.3M underscores the firm's robust position within the competitive Georgia healthcare landscape. By leveraging these financial resources, the practice continues to solidify its operational footprint, ensuring that its multi-disciplinary team of dermatologists and pathologists remains at the forefront of clinical excellence.

The trajectory of MetroDerm reflects a disciplined approach to scaling medical services. Since its inception in 2003, the organization has evolved from a localized practice into a multi-site enterprise, demonstrating consistent growth through strategic debt financing. This recent capital injection serves as a testament to the firm's stability and its ongoing commitment to expanding high-quality dermatologic and surgical care across the Atlanta metropolitan area and beyond.

What is MetroDerm?

MetroDerm

Hospitals & Physicians Clinics

Physicians Clinics

Medical Practice Management

MetroDerm, P.C. is a premier dermatological practice founded by D.J. Papadopoulos, M.D., dedicated to providing comprehensive medical and surgical skin care. Operating across three strategic locations in metro Atlanta and Paulding/West Cobb County, the practice distinguishes itself through a collaborative model that integrates five dermatologists, a pathologist, and specialized physician assistants. The company maintains a rigorous standard for clinical efficacy, evaluating every technological advancement for safety before implementation. By fostering an environment of mutual trust and respect, MetroDerm has established itself as a leader in patient-centric dermatologic services, prioritizing ethical standards and continuous professional education to meet the diverse needs of its patient base.

How much funding has MetroDerm raised?

MetroDerm has raised a total of $2.3M across 2 funding rounds:

2020

Debt

$1M

2021

Debt

$1.3M

Debt (2020): $1M with participation from PPP

Debt (2021): $1.3M led by PPP

Key Investors in MetroDerm

PPP

Public-Private Partnership

What's next for MetroDerm?

With the recent influx of capital, MetroDerm is well-positioned to enhance its service delivery model and potentially broaden its clinical reach. The firm's focus remains on the integration of advanced dermatologic technologies and the maintenance of its high-touch, patient-first environment. As the practice navigates the complexities of the modern healthcare market, this strategic financing will likely support infrastructure upgrades and the continued recruitment of top-tier medical talent. By maintaining its focus on surgical precision and evidence-based care, MetroDerm is poised to sustain its competitive advantage and deepen its market penetration within the Georgia healthcare sector.

See full MetroDerm company page

See More Financial Insights